BUZZ-London-listed Indivior falls; drugmaker effects board changes after investor pressure

Reuters12-17 19:32
BUZZ-London-listed Indivior falls; drugmaker effects board changes after investor pressure

** Shares of London-listed drugmaker Indivior INDV.L fall as much as 4.6% to 906.5p

** Company says its finance chief Ryan Preblick will step down as director as the group makes changes to its board following pressure from No. 2 shareholder Oaktree Capital

** INDV appoints Robert Schriesheim and Joe Ciaffoni as independent non-executive directors

** Says it has agreed to move towards a more standard U.S. system of remuneration for directors following its recent primary listing in New York

** "Fixing Indivior is not going to happen overnight and Oaktree's minor victory might simply be the first step in a complicated repair job" - AJ Bell

** Currently, stock down 3.4%, taking YTD losses to ~23%

(Reporting by Aby Jose Koilparambil in Bengaluru)

((abyjose.koilparambil@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment